Bioanalytical Systems to Release Second Quarter Fiscal 2017 Results on Monday, May 15, 2017

WEST LAFAYETTE, Ind.--()--Bioanalytical Systems, Inc. (NASDAQ:BASI) (“BASi” or the “Company”) today announced today that it will report financial results for the second quarter and six months ended March 31, 2017, prior to the market opening on Monday, May 15, 2017.

If there are any questions after the press release is issued, please direct your comments to the investor relations contact noted in this release.

About Bioanalytical Systems, Inc.

BASi is a pharmaceutical development company providing contract research services and monitoring instruments to the world's leading drug development companies and medical research organizations. The company focuses on developing innovative services and products that increase efficiency and reduce the cost of taking a new drug to market. Visit www.BASinc.com for more about BASi.

This release may contain forward-looking statements that are subject to risks and uncertainties including, but not limited to, risks and uncertainties related to changes in the market and demand for our products and services, the development, marketing and sales of products and services, changes in technology, industry standards and regulatory standards, and various market and operating risks detailed in the company's filings with the Securities and Exchange Commission.

Contacts

Bioanalytical Systems, Inc.
Jill C. Blumhoff, 765-497-8381
Chief Financial Officer
jblumhoff@BASinc.com

Recent Stories

  • BASi Reports Second Quarter Results
    May 15, 2017
    WEST LAFAYETTE, Ind.--(EON: Enhanced Online News)--Bioanalytical Systems, Inc. (NASDAQ:BASI) (“BASi” or the “Company”) today announced financial results for the second quarter and first six months ... more »
  • BASi Announces Appointment of Scientific Advisor
    May 01, 2017
    WEST LAFAYETTE, Ind.--(EON: Enhanced Online News)--Bioanalytical Systems, Inc. (NASDAQ:BASI) (“BASi” or the “Company”) today announced its Board of Directors has appointed Dr. Peter T. Kissinger, f... more »
  • View Press Release
    BASi Names Philip A. Downing Senior Vice President of Preclinical Services
    March 08, 2017
    Photo
    WEST LAFAYETTE, Ind.--(EON: Enhanced Online News)--Bioanalytical Systems, Inc. (NASDAQ:BASI) (“BASi” or the “Company”) today announced that Philip A. Downing has been promoted to Senior Vice Presid... more »
RSS feed for Bioanalytical Systems, Inc.

Release Summary

Earnings Release Announcement - Earnings to be announced May 15 prior to the opening.

Bioanalytical Systems, Inc.